Yale Skin Cancer Pilot Projects
Developmental Research Program (DRP)
Small pilot projects at Yale aim to speed up new ways to prevent, detect, or treat skin cancers for people affected by or at risk for those diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11181042 on NIH RePORTER |
What this research studies
Yale's developmental program provides small, short-term funding (typically up to $50,000 per year for one to two years) to support early-stage projects that could lead to new ways to prevent, detect, or treat skin cancers. Projects are required to have a clear path toward clinical use and often involve human samples, patient-focused technologies, or plans for future clinical testing. The program supports multiple pilot projects each year and leverages institutional matching funds to strengthen promising proposals. Successful pilots can expand into larger externally funded studies or be incorporated into Yale's broader skin cancer research effort.
Who could benefit from this research
Good fit: Ideal candidates are people with cutaneous skin cancers (such as basal cell carcinoma or cutaneous squamous cell carcinoma) or those at high risk who might join future pilot studies or clinical trials stemming from this program.
Not a fit: People without skin disease or those needing immediate standard-of-care treatment are unlikely to receive direct benefit from these early-stage pilot projects.
Why it matters
Potential benefit: If successful, these pilots could speed the development of new prevention, diagnostic, or treatment options for basal cell and squamous cell skin cancers.
How similar studies have performed: Previous SPORE developmental programs have helped many early ideas grow into larger grants and clinical trials, though outcomes vary by project.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Stern, David F — Yale University
- Study coordinator: Stern, David F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.